Authors:
Vincenzo De Luca
1
;
Lutgarda Bozzetto
2
;
Clemente Giglio
2
;
Giovanni Tramontano
2
;
Carlos Juan Chiatti
3
;
Fotis Gonidis
4
;
Strahil Birov
5
;
Ozan Beyhan
6
;
Simon Robinson
5
;
Gorka Sanchez-Nanclares
7
;
Maria del Pilar López-Acuña
8
;
Adriano Fernandes
9
;
Maria del Pilar Triassi
1
;
Giovanni Annuzzi
2
;
Guido Iaccarino
1
and
Maddalena Illario
1
Affiliations:
1
Dipartimento di Sanità Pubblica, Università degli Studi di Napoli “Federico II”, via S. Pansini 5, Naples, Italy
;
2
Azienda Ospedaliera Universitaria Federico II, via S. Pansini 5, Naples, Italy
;
3
Tech4Care Srl, Via Guglielmo Marconi 31, 60015 Falconara Marittima AN, Italy
;
4
Gnomon Informatics SA, Antoni Tritsi 21, 57001, Thessaloniki, Greece
;
5
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH, Oxfordstr. 2, Bonn, Germany
;
6
Ministry of Health Turkey, Üniversiteler Mah. 6001. Cad. No. 9, Ankara, Turkey
;
7
Servicio Murciano de Salud, Central, 7 Edificio “Habitamia”- 5ª, 30100 Murcia, Spain
;
8
FFIS, Luis Fontes Pagán, 9. 1ª, 30003 Murcia, Spain
;
9
Misericordia of Amadora, Innovation Department, Estrada da Portela-Quinta das Torres, Amadora, Portugal 10Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli “Federico II”, via S. Pansini 5, Naples, Italy
Keyword(s):
ICT, Diabetes Mellitus, Management, Satisfaction, Usability, mHealth.
Abstract:
The growing digitalization of health and care calls for the development of ICT tools and mHealth solutions to monitor and control the patient’s health parameters and lifestyles. ProEmpower is a Pre Commercial Procurement project aimed at procuring research and development services to develop innovative solutions for patient empowerment and self-management of Type 2 Diabetes Mellitus. The project consortium launched a call for tenders, articulated in 3 phases to select solutions. During Phase III, two solutions have been selected to be tested by end-users: DM4All and DiaWatch. A pilot study has been carried out to evaluate direct and indirect outcomes linked to the use of the novel solutions. Among these, we assessed the post-intervention satisfaction, self-management and usability of the two novel solutions, using a 5-point Likert scale questionnaire. Users expressed a favourable opinion on both solutions, evaluating the experience during the pilot phase as positive. DM4All results a
re better, however, the questionnaire completion rate was higher in DiaWatch. Users appreciated DM4All for its usefulness in managing their conditions.
(More)